Amy L.  Ladd net worth and biography

Amy Ladd Biography and Net Worth

Director of Intuitive Surgical
Amy L. Ladd, M.D. has been a member of our Board of Directors since August 2019. Dr. Ladd has spent nearly three decades practicing orthopaedic surgery at Stanford University. Dr. Ladd has served as the Elsbach-Richards Professor of Surgery since December 2017, and as Professor of Orthopaedic Surgery, as well as Professor of Medicine (Immunology & Rheumatology), by courtesy, at the Stanford University Medical Center since 2003.

Dr. Ladd has served as a member of the Board of Directors of the Perry Initiative since September 2013.

Dr. Ladd also served as the chair of the American Academy of Orthopaedic Surgeons (AAOS) Board of Specialty Societies from March 2018 to March 2019 and previously served as a member of the Board of Directors of the AAOS from March 2016 to March 2019.

Dr. Ladd received her M.D. from SUNY Upstate Medical University, completed Orthopaedic Residency at the University of Rochester, and completed the Harvard Combined Hand Surgery Fellowship. Dr. Ladd was a fellow at L'Institut de la Main in Paris, France prior to joining the Stanford University faculty in 1990. She earned her A.B. in History from Dartmouth College.

What is Amy L. Ladd's net worth?

The estimated net worth of Amy L. Ladd is at least $217,283.04 as of September 14th, 2023. Dr. Ladd owns 702 shares of Intuitive Surgical stock worth more than $217,283 as of December 6th. This net worth evaluation does not reflect any other investments that Dr. Ladd may own. Learn More about Amy L. Ladd's net worth.

How do I contact Amy L. Ladd?

The corporate mailing address for Dr. Ladd and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on Amy L. Ladd's contact information.

Has Amy L. Ladd been buying or selling shares of Intuitive Surgical?

Amy L. Ladd has not been actively trading shares of Intuitive Surgical during the last quarter. Most recently, Amy L. Ladd sold 500 shares of the business's stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $305.68, for a transaction totalling $152,840.00. Following the completion of the sale, the director now directly owns 702 shares of the company's stock, valued at $214,587.36. Learn More on Amy L. Ladd's trading history.

Who are Intuitive Surgical's active insiders?

Intuitive Surgical's insider roster includes Craig Barratt (Director), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.

Are insiders buying or selling shares of Intuitive Surgical?

During the last year, insiders at the medical equipment provider sold shares 26 times. They sold a total of 272,696 shares worth more than $78,133,646.04. The most recent insider tranaction occured on November, 16th when Director Amal M Johnson sold 9,567 shares worth more than $2,870,100.00. Insiders at Intuitive Surgical own 0.9% of the company. Learn More about insider trades at Intuitive Surgical.

Information on this page was last updated on 11/16/2023.

Amy L. Ladd Insider Trading History at Intuitive Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2023Sell500$305.68$152,840.00702View SEC Filing Icon  
7/24/2020Sell55$665.13$36,582.15128View SEC Filing Icon  
See Full Table

Amy L. Ladd Buying and Selling Activity at Intuitive Surgical

This chart shows Amy L Ladd's buying and selling at Intuitive Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intuitive Surgical Company Overview

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $310.52
Low: $308.61
High: $313.60

50 Day Range

MA: $288.35
Low: $258.49
High: $318.01

2 Week Range

Now: $310.52
Low: $222.65
High: $358.07


300,658 shs

Average Volume

1,748,971 shs

Market Capitalization

$109.33 billion

P/E Ratio


Dividend Yield